Fundraising Fox

Esperancepharma

Houston, US · 1 known investors

esperancepharma.com ↗

Esperance Pharmaceuticals develops targeted anticancer drugs designed to bind specific receptors on cancer cell surfaces and selectively kill cancer cells, including chemotherapy-resistant cells, while sparing normal cells. Its lead candidate EP-100 is being developed with MD Anderson Cancer Center for ovarian and breast cancer.

BiotechHealthtech

Founders & leadership

HA
Hector AlilaExecutive Officer, Director
RB
Ross BarrettDirector
JL
Joseph LovettDirector
PH
Peter HoangDirector
SD
Sonia DeggsExecutive Officer
CL
Carola LeuschnerExecutive Officer

Investors · 1

Louisiana FundsBaton Rouge

Reported raises · per SEC filings

Form D private placements
▶$1MraisedJul 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Hector AlilaExecutive Officer, Director
  • Ross BarrettDirector
  • Joseph LovettDirector
  • Peter HoangDirector
  • Sonia DeggsExecutive Officer
  • Carola LeuschnerExecutive Officer
Offering amount
$1M
Amount sold
$1M
Proceeds to insiders
$100K
First sale
Jun 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.